ARZART

Serial Number 77592507
606

Registration Progress

Application Filed
Oct 14, 2008
Under Examination
Jun 15, 2010
Approved for Publication
Feb 4, 2009
Published for Opposition
Feb 24, 2009
Registered

Trademark Image

ARZART

Basic Information

Serial Number
77592507
Filing Date
October 14, 2008
Published for Opposition
February 24, 2009
Abandonment Date
July 15, 2013
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Jul 15, 2013
Classes
005

Rights Holder

DAIICHI SANKYO COMPANY, LIMITED

09
Address
3-5-1, Nihonbashi Honcho
Chuo-ku, Tokyo 103-8426
JP

Ownership History

DAIICHI SANKYO COMPANY, LIMITED

Original Applicant
09
Chuo-ku, Tokyo JP

DAIICHI SANKYO COMPANY, LIMITED

Owner at Publication
09
Chuo-ku, Tokyo JP

Legal Representation

Attorney
Ray Thomas, Jr.

USPTO Deadlines

All Deadlines Cleared

All 4 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

44 events
Date Code Type Description Documents
Jul 15, 2013 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Jul 15, 2013 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED Loading...
Jan 10, 2013 EXRA O NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED Loading...
Jan 9, 2013 EX5G S SOU EXTENSION 5 GRANTED Loading...
Dec 5, 2012 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Dec 5, 2012 EXT5 S SOU EXTENSION 5 FILED Loading...
Jun 19, 2012 EXRA O NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED Loading...
Jun 18, 2012 EX4G S SOU EXTENSION 4 GRANTED Loading...
Jun 12, 2012 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 12, 2012 EXT4 S SOU EXTENSION 4 FILED Loading...
Dec 2, 2011 EXRA O NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED Loading...
Nov 30, 2011 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 30, 2011 EXT3 S SOU EXTENSION 3 FILED Loading...
Nov 30, 2011 EX3G S SOU EXTENSION 3 GRANTED Loading...
Jun 8, 2011 EXRA O NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED Loading...
Jun 7, 2011 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Jun 7, 2011 EX2G S SOU EXTENSION 2 GRANTED Loading...
Jun 2, 2011 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 2, 2011 EXT2 S SOU EXTENSION 2 FILED Loading...
Dec 1, 2010 EXRA O NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED Loading...
Nov 29, 2010 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 29, 2010 EXT1 S SOU EXTENSION 1 FILED Loading...
Nov 29, 2010 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jun 15, 2010 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT Loading...
May 5, 2010 OP.D T OPPOSITION DISMISSED NO. 999999 Loading...
May 5, 2010 OP.T T OPPOSITION TERMINATED NO. 999999 Loading...
May 5, 2010 TMBN T TTAB RELEASE CASE TO TRADEMARKS Loading...
Apr 23, 2010 MAIL I PAPER RECEIVED Loading...
Aug 20, 2009 OP.I T OPPOSITION INSTITUTED NO. 999999 Loading...
Mar 11, 2009 ETOF T EXTENSION OF TIME TO OPPOSE RECEIVED Loading...
Feb 24, 2009 PUBO A PUBLISHED FOR OPPOSITION Loading...
Feb 18, 2009 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Feb 4, 2009 NPUB O NOTICE OF PUBLICATION Loading...
Jan 21, 2009 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jan 21, 2009 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Jan 16, 2009 ALIE A ASSIGNED TO LIE Loading...
Jan 16, 2009 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jan 16, 2009 ACEC I AMENDMENT FROM APPLICANT ENTERED Loading...
Jan 13, 2009 MAIL I PAPER RECEIVED Loading...
Dec 30, 2008 CNRT F NON-FINAL ACTION MAILED Loading...
Dec 29, 2008 DOCK D ASSIGNED TO EXAMINER Loading...
Dec 29, 2008 CNRT R NON-FINAL ACTION WRITTEN Loading...
Oct 18, 2008 MPMK O NOTICE OF PSEUDO MARK MAILED Loading...
Oct 17, 2008 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment and prevention of cardiovascular disease, atherosclerosis, diabetic nephropathy, stroke, heart attack, hypercholesterolemia, dyslipidemia, anemia, blood disorders, diabetes, thyroid function disease, metabolic disorders, cancer, oncological disease, metastasis, autoimmune disease, allergy, bacterial infection, viral infection, fungal infection, inflammation and inflammatory disease, musculoskeletal disorders, pain, osteoporosis, Alzheimer's disease, obesity, anorexia, urinary and kidney disease, respiratory disease; Diagnostic reagents and contrast media for medical use; all of the foregoing excluding ophthalmic pharmaceutical preparations
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005